New drug offers hope for celiac patients still suffering despite Gluten-Free diet
Disease control
Completed
This study tested an experimental drug called PRV-015 in 388 adults with non-responsive celiac disease—meaning they still have symptoms even after following a strict gluten-free diet. The goal was to see if the drug could reduce belly pain, bloating, cramping, and gas compared to…
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC